Kathmandu Nepal November 2020 Syringe Injection Infront Moderna Logo Moderna — Stock Photo, Image
Editorial Use Only

Kathmandu, Nepal - November 24 2020: Syringe Injection infront of Moderna Logo. Moderna vaccine has shown 94% effectiveness against COVID-19 in Phase 3 of human trial. — Stock Editorial Photography

Kathmandu, Nepal - November 24 2020: Syringe Injection infront of Moderna Logo. Moderna vaccine has shown 94% effectiveness against COVID-19 in Phase 3 of human trial.

 — Photo by sirajstock

Same Series:

Kathmandu, Nepal - February 7 2021: Syringe Injection placed against Johnson and Johnson logo. JnJ coronavirus vaccine will work with only 1 dose as compared to two doses required by other vaccines.
Kathmandu Nepal February 2021 Syringe Injection Placed Johnson Johnson Logo — Stock Photo, Image
Kathmandu, Nepal - February 7 2021: Syringe Injection placed against Johnson and Johnson logo. JnJ coronavirus vaccine will work with only 1 dose as compared to two doses required by other vaccines.
Kathmandu Nepal February 2021 Syringe Injection Placed Johnson Johnson Logo — Stock Photo, Image
Kathmandu, Nepal - November 24 2020: Syringe Injection infront of AstraZeneca Logo. AstraZeneca vaccine has shown 90% effectiveness against COVID-19 in Phase 3 of human trial.
Kathmandu Nepal November 2020 Syringe Injection Infront Astrazeneca Logo Astrazeneca — Stock Photo, Image
Kathmandu, Nepal - November 28 2020: Man holds empty syringe against AstraZeneca Logo.
Kathmandu Nepal November 2020 Man Holds Empty Syringe Astrazeneca Logo — Stock Photo, Image
Kathmandu, Nepal - December 02 2020: COVID-19 Vaccine Concept. Syringe full of vaccine dose infront of Pfizer BioNTech Logo. Pfizer vaccine becomes first to be approved for mass usage in the world.
Kathmandu Nepal December 2020 Covid Vaccine Concept Syringe Full Vaccine — Stock Photo, Image
Kathmandu, Nepal - February 7 2021: Syringe Injection placed against Johnson and Johnson logo. JnJ coronavirus vaccine will work with only 1 dose as compared to two doses required by other vaccines.
Kathmandu Nepal February 2021 Syringe Injection Placed Johnson Johnson Logo — Stock Photo, Image
Kathmandu, Nepal - November 28 2020: Empty Syringe placed on a reflective surface against AstraZeneca logo. Oxford University and AstraZeneca are working on COVID-19 vaccine.
Kathmandu Nepal November 2020 Empty Syringe Placed Reflective Surface Astrazeneca — Stock Photo, Image
Kathmandu, Nepal - January 03 2021: Closeup of a syringe against Sputnik Light Vial.
Kathmandu Nepal January 2021 Closeup Syringe Sputnik Light Vial — Stock Photo, Image
Kathmandu, Nepal - February 7 2021: Syringe Injection placed against Johnson and Johnson logo. JnJ coronavirus vaccine will work with only 1 dose as compared to two doses required by other vaccines.
Kathmandu Nepal February 2021 Syringe Injection Placed Johnson Johnson Logo — Stock Photo, Image
Kathmandu, Nepal - January 03 2021: Closeup of a syringe against Sinopharm logo
Kathmandu Nepal January 2021 Closeup Syringe Sinopharm Logo — Stock Photo, Image
Kathmandu, Nepal - November 28 2020: Man holds empty syringe against AstraZeneca Logo.
Kathmandu Nepal November 2020 Man Holds Empty Syringe Astrazeneca Logo — Stock Photo, Image
Kathmandu, Nepal - November 24 2020: Syringe Injection infront of Pfizer Logo. Pfizer and BioNTechvaccine has shown 94% effectiveness against COVID-19 in Phase 3 of human trial.
Kathmandu Nepal November 2020 Syringe Injection Infront Pfizer Logo Pfizer — Stock Photo, Image
Empty Syringe against white void with copyspace.
Empty Syringe White Void Copyspace — Stock Photo, Image
Kathmandu, Nepal - November 24 2020: Syringe Injection infront of Pfizer Logo. Pfizer and BioNTechvaccine has shown 94% effectiveness against COVID-19 in Phase 3 of human trial.
Kathmandu Nepal November 2020 Syringe Injection Infront Pfizer Logo Pfizer — Stock Photo, Image
Syringe Icon vector illustration. Concept of vaccine or flu shot.
Syringe Icon Vector Illustration Concept Vaccine Flu Shot — Stock Vector
Empty Syringe against white void with copyspace.
Empty Syringe White Void Copyspace — Stock Photo, Image

Usage Information

You can use this royalty-free editorial photo "Kathmandu, Nepal - November 24 2020: Syringe Injection infront of Moderna Logo. Moderna vaccine has shown 94% effectiveness against COVID-19 in Phase 3 of human trial." for personal and non-commercial purposes according to the Standard License. This stock image may be used to illustrate stories in newspaper and magazine articles and blog posts. Please note that editorial stock photos may not be used in advertising or promotional material.

You can buy this editorial photograph and download it in high resolution up to 4176x2784. Upload Date: Nov 24, 2020